SPONSOR: Myers
COMMITTEE ACTION: Voted "Do Pass" by the Standing Committee on Emerging Issues by a vote of 12 to 0.
This bill modifies current law on the use of investigational drugs and devices for individuals with terminal illnesses to include those individuals with life-threatening or severely debilitating conditions or illnesses.
Currently, investigational drugs do not include Schedule I controlled substances. This bill repeals that prohibition.
This bill is similar to SB 1454 (2026).
PROPONENTS: Supporters say that allowing the medical establishment to provide their patients with the fullest possible range of drugs and medications is beneficial for all involved, especially those patients who are suffering from severe and debilitating conditions.
Testifying in person for the bill were Representative Myers; and Arnie Dienoff.
OPPONENTS: There was no opposition voiced to the committee.
Written testimony has been submitted for this bill. The full written testimony and witnesses testifying online can be found under Testimony on the bill page on the House website.
Statutes affected: